Mannose-binding lectin protein and its association to clinical outcomes in COPD: A longitudinal study

Respiratory Research

Volumn 16, Issue 1, 2015, Pages

  Mandal, Jyotshna ^a   Malla, Bijaya ^a   Steffensen, Rudi ^b   Costa, Luigi ^a   Egli, Adrian ^a   Trendelenburg, Marten ^a   Blasi, Francesco ^c   Kostikas, Kostantinos ^d   Welte, Tobias ^e   Torres, Antoni ^f   Louis, Renaud ^g   Boersma, Wim ^h   Milenkovic, Branislava ⁱ   Aerts, Joachim ^j   Rohde, Gernot G U ^k   Lacoma, Alicia ^l   Rentsch, Katharina ^a   Roth, Michael ^a   Tamm, Michael ^a   Stolz, Daiana ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MILAN   (Italy)

^d Medical School   (Greece)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f HOSPITAL CLÍNIC   (Spain)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h Medical Centre Alkmaar   (Netherlands)

ⁱ UNIVERSITY OF BELGRADE   (Serbia)

^j AMPHIA HOSPITAL   (Netherlands)

^k MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^l HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

more..

Author keywords

Exacerbation; Haplotypes; Lung function; Survival rate

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2; MBL2 PROTEIN, HUMAN;

AGED; ARTICLE; BACTERIAL COLONIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HAPLOTYPE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANNOSE BINDING LECTIN 2 GENE; PROGNOSIS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; BLOOD; CLINICAL TRIAL; DISEASE COURSE; EUROPE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; KAPLAN MEIER METHOD; LUNG; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; DISEASE PROGRESSION; EUROPE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; LUNG; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84951112628     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-015-0306-3     Document Type: Article

References (45)

1. World Health Organization. Burden of COPD. [ http://www.who.int/respiratory/copd/burden/en/ ]
2. Global Strategy for the Diagnosis, Management and Prevention of COPD. Guidelines. 2015. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Sept2.pdf
3. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128-38.
4. Lin CL, Siu LK, Lin JC, Liu CY, Chian CF, Lee CN, et al. Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPD. Chest. 2011;139:43-51.
5. Lacroix M, Dumestre-Perard C, Schoehn G, Houen G, Cesbron JY, Arlaud GJ, et al. Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. J Immunol. 2009;182:456-65.
6. Adamek M, Heyder J, Heinold A, Fiedler G, Opelz G, Tran TH. Characterization of mannose-binding lectin (MBL) variants by allele-specific sequencing of MBL2 and determination of serum MBL protein levels. Tissue Antigens. 2013;82:410-5.
7. Eisen DP. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun. 2010;2:114-22.
8. Chalmers JD, McHugh BJ, Doherty C, Smith MP, Govan JR, Kilpatrick DC, et al. Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study. Lancet Respir Med. 2013;1:224-32.
9. Stolz D, Boersma W, Blasi F, Louis R, Milenkovic B, Kostikas K, et al. Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest. 2014;146:328-38.
10. Russi EW, Karrer W, Brutsche M, Eich C, Fitting JW, Frey M, et al. Diagnosis and management of chronic obstructive pulmonary disease: the swiss guidelines. Official guidelines of the swiss respiratory society. Respiration. 2013;85:160-74.
11. Isenberg H. Clinical microbiology procedures handbook. Washington: Blackwell; 1992.
12. Henckaerts L, Nielsen KR, Steffensen R, Van Steen K, Mathieu C, Giulietti A, et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med. 2009;37:192-201. e1-3.
13. Molle I, Steffensen R, Thiel S, Peterslund NA. Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes. Eur J Haematol. 2006;77:19-26.
14. Hoeflich C, Unterwalder N, Schuett S, Schmolke K, Boenisch O, Hammer M, et al. Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency. Hum Immunol. 2009;70:809-12.
15. Olesen HV, Jensenius JC, Steffensen R, Thiel S, Schiotz PO. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol. 2006;121:324-31.
16. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun. 2006;7:85-94.
17. Boldt AB, Culpi L, Tsuneto LT, de Souza IR, Kun JF, Petzl-Erler ML. Diversity of the MBL2 gene in various Brazilian populations and the case of selection at the mannose-binding lectin locus. Hum Immunol. 2006;67:722-34.
18. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155:3013-20.
19. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods. 2000;241:33-42.
20. Steffensen R, Hoffmann K, Varming K. Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods. 2003;278:191-9.
21. Alves Pedroso ML, Boldt AB, Pereira-Ferrari L, Steffensen R, Strauss E, Jensenius JC, et al. Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clin Exp Immunol. 2008;152:258-64.
22. Heitzeneder S, Seidel M, Forster-Waldl E, Heitger A. Mannan-binding lectin deficiency - Good news, bad news, doesn't matter? Clin Immunol. 2012;143:22-38.
23. Crosdale DJ, Ollier WE, Thomson W, Dyer PA, Jensenious J, Johnson RW, et al. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogenet. 2000;27:111-7.
24. Pine SR, Mechanic LE, Ambs S, Bowman ED, Chanock SJ, Loffredo C, et al. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst. 2007;99:1401-9.
25. Ocejo-Vinyals JG, Lavin-Alconero L, Sanchez-Velasco P, Guerrero-Alonso MA, Ausin F, Farinas MC, et al. Mannose-binding lectin promoter polymorphisms and gene variants in pulmonary tuberculosis patients from cantabria (northern Spain). Pulm Med. 2012;2012:469128.
26. Collard CD, Shernan SK, Fox AA, Bernig T, Chanock SJ, Vaughn WK, et al. The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery. Circulation. 2007;116:I106-12.
27. Tomaiuolo R, Degiorgio D, Coviello DA, Baccarelli A, Elce A, Raia V, et al. An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study. Dig Liver Dis. 2009;41:817-22.
28. Boldt AB, Messias-Reason IJ, Meyer D, Schrago CG, Lang F, Lell B, et al. Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet. 2010;11:38.
29. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193-201.
30. Degn SE, Jensenius JC, Thiel S. Disease-causing mutations in genes of the complement system. Am J Hum Genet. 2011;88:689-705.
31. Herpers BL, Endeman H, de Jong BA, de Jongh BM, Grutters JC, Biesma DH, et al. Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol. 2009;156:488-94.
32. Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC. Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology. 2011;21:271-82.
33. Eagan TM, Aukrust P, Bakke PS, Damas JK, Skorge TD, Hardie JA, et al. Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respir Med. 2010;104:283-90.
34. Watkins C, Saleh H, Song E, Jaishankar GB, Chi DS, Misran N, et al. Concomitant gene mutations of MBL and CYBB in chronic granulomatous disease: implications for host defense. Inflamm Allergy Drug Targets. 2012;11:222-6.
35. Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998;102:2146-55.
36. Rantala A, Lajunen T, Juvonen R, Bloigu A, Silvennoinen-Kassinen S, Peitso A, et al. Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J Infect Dis. 2008;198:1247-53.
37. Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med. 2004;199:1391-9.
38. van Kessel DA, Hoffman TW, van Velzen-Blad H, Zanen P, Rijkers GT, Grutters JC. Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections. Clin Exp Immunol. 2014;177:272-9.
39. Scudiero O, Monaco ML, Nigro E, Capasso M, Guida M, Di Spiezio SA, et al. Mannose-binding lectin genetic analysis: possible protective role of the HYPA haplotype in the development of recurrent urinary tract infections in men. Int J Infect Dis. 2014;19:100-2.
40. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun. 2000;68:688-93.
41. Yang IA, Seeney SL, Wolter JM, Anders EM, McCormack JG, Tunnicliffe AM, et al. Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes Immun. 2003;4:269-74.
42. Bay JT, Sorensen SS, Hansen JM, Madsen HO, Garred P. Low mannose-binding lectin serum levels are associated with reduced kidney graft survival. Kidney Int. 2013;83:264-71.
43. Gordon AC, Waheed U, Hansen TK, Hitman GA, Garrard CS, Turner MW, et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock. 2006;25:88-93.
44. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308-11.
45. Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, et al. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:139-48.